
### [NCIT:C3618](http://purl.obolibrary.org/obo/NCIT_C3618)
**Label:** Benign Bladder Neoplasm

**Subclasses:** [NCIT:C6178](http://purl.obolibrary.org/obo/NCIT_C6178) (Bladder Leiomyoma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma), 

**Class expressions from DL-Learner:**

- Thing 52.12%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39711](http://purl.obolibrary.org/obo/NCIT_C39711) (C-KIT Tyrosine Kinase Protein Overexpression))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39709](http://purl.obolibrary.org/obo/NCIT_C39709) (Confluent Sheets of Anaplastic T-Lymphocytes Present))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39708](http://purl.obolibrary.org/obo/NCIT_C39708) (Cerebriform-Like Lymphocyte))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C3970](http://purl.obolibrary.org/obo/NCIT_C3970) (Kidney Cyst))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39695](http://purl.obolibrary.org/obo/NCIT_C39695) (Extranodal Disease))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39692](http://purl.obolibrary.org/obo/NCIT_C39692) (Complete Spontaneous Regression))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39691](http://purl.obolibrary.org/obo/NCIT_C39691) (Partial Spontaneous Regression))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39690](http://purl.obolibrary.org/obo/NCIT_C39690) (Papular Lesion))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39689](http://purl.obolibrary.org/obo/NCIT_C39689) (Multicentric Cutaneous Involvement))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39688](http://purl.obolibrary.org/obo/NCIT_C39688) (Localized Skin Lesion))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39687](http://purl.obolibrary.org/obo/NCIT_C39687) (Activated Mature Cytotoxic T-Lymphocyte))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39686](http://purl.obolibrary.org/obo/NCIT_C39686) (Activated Skin-Homing T-Lymphocyte))) 42.50%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39682](http://purl.obolibrary.org/obo/NCIT_C39682) (Flower-Like T-Lymphocyte))) 42.50%


